Higher Rated
Dukascopy
Capital at risk · T&Cs apply
Compare Phillip Nova and Dukascopy side by side on fees, regulation, platforms and our expert ratings. Find out which broker suits your needs.
Phillip Nova
Dukascopy
Dukascopy is the better choice overall, scoring 3.7/5 vs 3.4/5 on BrokerRank's independent rating. On fees, Dukascopy offers lower spreads (0.1 pips).
See full side-by-side comparison belowOverall Rating
Dukascopy
3.4 vs 3.7
Lowest Fees
Dukascopy
0.6 vs 0.1 pips
Regulation
Dukascopy
1 vs 2 licences
Min. Deposit
Phillip Nova
$0 vs $100
Phillip Nova
Dukascopy
WinnerPhillip Nova
Dukascopy
Phillip Nova scores 3.39/5 while Dukascopy scores 3.71/5 in our independent rating.
Dukascopy edges ahead overall, but Phillip Nova may suit traders who prioritise different features. Read our full reviews for a detailed breakdown. Scores are based on our transparent methodology.
Dukascopy scores higher overall on our independent rating system. Phillip Nova holds a 3.4/5 rating vs Dukascopy's 3.7/5. The best choice ultimately depends on your trading style — see our full verdict above for a detailed breakdown.
Phillip Nova offers spreads from 0.6 pips, while Dukascopy starts at 0.1 pips. Check the fees section above for a full breakdown.
Phillip Nova requires a minimum deposit of $0. Dukascopy requires $100.
Phillip Nova is regulated by MAS, while Dukascopy holds licences from FCA, MAS.
Phillip Nova supports Proprietary Web, Proprietary Mobile, POEMS. Dukascopy supports Proprietary Web, Proprietary Mobile, MT4.
Yes, you can hold accounts at multiple brokers simultaneously. Many traders diversify across platforms to access different markets and tools.
Only 26% of Brokers Are Truly Fee-Free
BrokerRank Research — Hidden costs across 345 brokers
58% of Brokers Hold a Single Licence
BrokerRank Research — Regulation quality analysis
71% of Retail Traders Lose Money
BrokerRank Research — Loss rates across 50 EU brokers
76% of Brokers Use Proprietary Platforms
BrokerRank Research — MT4 vs MT5 vs proprietary
Trading involves risk. Past performance is not indicative of future results. Capital at risk. Full risk disclosure.